Trials / Completed
CompletedNCT00847288
OptiVol® Care Pathway
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,682 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Medtronic, Inc. is sponsoring the OptiVol® Care Pathway Study, a prospective, randomized, multi-center, post-market clinical trial in the United States. The purpose of this clinical trial is to compare monthly versus quarterly review of Cardiac Compass® Trends with OptiVol for initiation of clinical action. It is hypothesized that monthly review of Cardiac Compass Trends with OptiVol will shorten time to clinical action as compared to quarterly review.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Monthly Review Arm | Monthly review of Cardiac Compass Trends with OptiVol. This intervention is related to disease management. |
| OTHER | Quarterly Review Arm | Quarterly review of Cardiac Compass Trends with OptiVol. This intervention is related to disease management. |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2011-03-01
- Completion
- 2011-05-01
- First posted
- 2009-02-19
- Last updated
- 2013-05-03
- Results posted
- 2013-05-03
Locations
108 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00847288. Inclusion in this directory is not an endorsement.